9.92 USD
↘ 0.35 (3.41%)AT CLOSE (11:59 AM EDT)
Atara Biotherapeutics, Inc
ATRANASDAQ • USD
9.98
↗ 0.06 (0.55%)
POST MARKET (AS OF 04:31 PM EDT)
Post Market
AS OF 04:31 PM EDT
9.98
↗ 0.06 (0.55%)
Market: CLOSED
Open?$10.18
High?$10.18
Low?$9.83
Prev. Close?$10.27
Volume?69.0K
Avg. Volume?2.9M
VWAP?$9.97
Rel. Volume?0.02x
Bid / Ask
Bid?$8.62 × 100
Ask?$11.38 × 100
Spread?$2.76
Midpoint?$10.00
Valuation & Ratios
Market Cap?89.4M
Shares Out?9.0M
Float?2.6M
Float %?36.0%
P/E Ratio?N/A
P/B Ratio?-2.40
EPS?-$1.05
Dividend?0.00%
Ex-Dividend?N/A
Atara Biotherapeutics, Inc (ATRA) trades at $9.92 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Strong Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (25.4%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place ATRA at a fair price relative to peers.
Technical & fundamental data as of Jun 5, 2026.
RelatedORIC
News
Profile
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Themes
Employees
13
Market Cap
89.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2014-10-16
Address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS, CA 91320
Phone: 805-623-4211
THOUSAND OAKS, CA 91320
Phone: 805-623-4211
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?2
Short Sent.?54
Piotroski F-Score?1/9Weak
Altman Z-Score?-140.40Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?21.08%Squeeze Risk
Short Interest?546.5K
Days to Cover?1.0
Free Float2.6M
Avg Daily Volume7.4M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.16Strong
Quick Ratio?2.16Strong
Cash Ratio?1.48Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?-2.40CHEAP▾
Peers100
S&P97
P/S?3.86FAIR▾
S&P39
P/FCF?N/A▾
EV/EBITDA?-13.6CHEAP▾
S&P97
EV/Sales?3.50FAIR▾
S&P54
Returns & Efficiency
ROE?25.4%STRONG▾
S&P74
ROA?-47.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$81.0M
Fundamentals ratios updated end of day